DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20184247

Classification and treatment of prostatitis: a review of literature

Saad Khalid Almugbel, Fahad Khalaf Bakit Alanezi, Faisal Musaad Alhoshan, Rayan Osama Alkhalifa, Ali Hasan Alkhzaim, Malik Abdulrahman Almohideb

Abstract


Prostatitis is one of the most common urinary tract diseases in men of all ages and is often challenging to manage. They can be classified based of the course of illness, presentation, and their etiology, and the investigation and treatment depend on how type of prostatitis. In this study we aim to look through the literature to find the various types of prostatitis and understand the respective methods of management. We did a systematic search for prostatitis using PubMed search engine (http://www.ncbi.nlm.nih.gov/) and Google Scholar search engine (https://scholar. google.com). The terms used in the search were: prostatitis, urinary tract diseases in men, classification of prostatitis, management of prostatitis. Prostatitis is a common disease and is considered to be the third most common urological disease in men. It has been categorized into four groups: acute bacterial prostatitis, chronic bacterial prostatitis, chronic prostatitis/chronic pelvic pain syndrome, and asymptomatic inflammatory prostatitis. Treatment can be challenging, but mainly consists of use of fluoroquinolones.

 


Keywords


Prostatitis, Categories, Fluoroquinolones

Full Text:

PDF

References


Schaeffer AJ. Chronic prostatitis and the chronic pelvic pain syndrome. New Engl J Med. 2006;355(16):1690–8.

Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001;165(3):842–5.

Rosette JJ, Hubregtse MR, Meuleman E, Stolk-Engelaar MV, Debruyne FM. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology. 1993;41(4):301–7.

JN Krieger, L Nyberg Jr, JC Nickel. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–7.

Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, et al. Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis. 2008;8:12.

Kim SH, Ha US, Yoon BI, Kim SW, Sohn DW, Kim HW, et al. Microbiological and clinical characteristics in acute bacterial prostatitis according to lower urinary tract manipulation procedure. J Infect Chemother. 2014;20(1):38–42.

Campeggi A, Ouzaid I, Xylinas E, Lesprit P, Hoznek A, Vordos D, et al. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study. Int J Urol. 2014;21(2):152–5.

Naber KG. Antimicrobial treatment of bacterial prostatitis. Eur Urol. 2003;2(2):23–6.

Neal DJ. Treatment of Acute Prostatitis, ISIS Medical Media, Oxford, 1999.

Johansen TE, Gruneberg RN, Guibert J, Hofstetter A, Lobel B, Naber KG, et al. The role of antibiotics in the treatment of chronic prostatitis:a consensus statement. Eur Urol. 1998;34(6):457–66.

Nickel JC. Recommendations for the evaluation of patients with prostatitis. World J Urol. 2003;21(2):75–81.

Budía A, Luis Palmero J, Broseta E, Tejadillos S, Benedicto A, Queipo JA, et al. Value of semen culture in the diagnosis of chronic bacterial prostatitis:a simplified method. Scand J Urol Nephrol. 2006;40(4):326–31.

Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, et al. EAU guidelines for the management of urinary and male genital tract infections: Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001;40(5):576-88.

Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol. 1998;159(3):883–7.

Schaeffer AJ, Landis JR, Knauss JS, Propert KJ, Alexander RB, Litwin MS. Demographic and clinical characteristics of men with chronic prostatitis:the national institutes of health chronic prostatitis cohort study. J Urol. 2002;168(2):593–8.

Wenninger K, Heiman JR, Rothman I, Berghuis JP, Berger RE. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol. 1996;155(3):965–8.

Khan FU, Ihsan AU, Nawaz W, Khan MZ, Yang M, Wang G, et al. A novel mouse model of chronic prostatitis/chronic pelvic pain syndrome induced by immunization of special peptide fragment with aluminum hydroxide adjuvant. Immunol Lett. 2017;187:61–7.

Mehik A, Hellström P, Sarpola A, Lukkarinen O, Järvelin MR. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross sectional study in Finland. BJU Int. 2001;88(1):35–8.

Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W. Idiopathic pain disorders– pathways of vulnerability. Pain. 2006;123(3):226–30.

Collins MM, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis:a systematic review. Ann Intern Med. 2000;133(5):367–81.

Nickel JC. Classification and diagnosis of prostatitis:a gold standard? Andrologia. 2003;35(3):160–7.

Weidner W, Anderson RU. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation. Int J Antimicrob Agents. 2008;31(1).

Kaplan SA, Te AE, Jacobs BZ. Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck. J Urol. 1994;152:2063–5.

Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial, Ann Intern Med. 2004;141(8):581–9.

Cho IR, Keener TS, Nghiem HV, Winter T, Krieger JN. Prostate blood flow characteristics in the chronic prostatitis/pelvic pain syndrome. J Urol. 2000;163(4):1130–3.

Mo KI, Lee KS, Kim DG. Efficacy of combination therapy for patients with chronic prostatitis/chronic pelvic pain syndrome:a prospective study. Korean J Urol. 2006;47(5):536–40.

Bach D, Walker H. How important are prostaglandins in the urology of man? Urol Int. 1982;37(3):160–71.

Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int. 2004;93(7):991-5.

Pontari MA, Krieger JN, Litwin MS, White PC, Anderson RU, McNaughton-Collins M, et al. Pregabalin for the Treatment of Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized Controlled Trial. Arch Internal Med. 2010;17:1586–93.

Nickel JC. Opioids for chronic prostatitis and interstitial cystitis:lessons learned from the 11th World Congress on Pain. Urology. 2006;68(4):697– 701.

Holt JD, Garrett WA, McCurry TK. Common questions about chronic prostatitis. Am Fam Physician. 2016;93 (4):290–6.

Clemens JQ1, Meenan RT, O'Keeffe Rosetti MC, Gao SY, Calhoun EA. Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community. J Urol. 2005;174(6):2319–22.

Stancik I, Luftenegger W, Klimpfinger M, Müller MM, Hoeltl W. Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol. 2004;46(6):760–4.